Technical Analysis for VNRX - VolitionRX Limited

Grade Last Price % Change Price Change
grade B 4.31 1.41% 0.06
VNRX closed down 0.23 percent on Thursday, September 19, 2019, on 43 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical VNRX trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 1.41%
Upper Bollinger Band Walk Strength 1.41%
Inside Day Range Contraction 1.41%
Overbought Stochastic Strength 1.41%
Upper Bollinger Band Touch Strength 1.41%
Wide Range Bar Range Expansion 1.17%
Overbought Stochastic Strength 1.17%
Upper Bollinger Band Touch Strength 1.17%
Pocket Pivot Bullish Swing Setup -1.15%
Wide Range Bar Range Expansion -1.15%

Older signals for VNRX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
VolitionRX Limited, a development stage life sciences company, focuses on developing cancer detection blood tests for detecting and diagnosing cancer and other diseases. It develops two blood tests in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer and nucleosomes containing specific histone variants. The company also develops nine blood tests in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones, the proteins that package, and order DNA into nucleosomes; and five blood tests in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts, as well as offers research kits. It develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help appropriate therapy; NuQ Endo endometriosis test; and NuQ clinical diagnostic products. VolitionRX Limited is based in Singapore.
Cancer Biology Diseases Disease Molecular Biology Epigenetics
Is VNRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.65
52 Week Low 1.67
Average Volume 130,041
200-Day Moving Average 3.1386
50-Day Moving Average 3.8968
20-Day Moving Average 3.8895
10-Day Moving Average 4.014
Average True Range 0.244
ADX 18.92
+DI 26.8681
-DI 13.0241
Chandelier Exit (Long, 3 ATRs ) 3.848
Chandelier Exit (Short, 3 ATRs ) 4.252
Upper Bollinger Band 4.3479
Lower Bollinger Band 3.4311
Percent B (%b) 0.89
BandWidth 23.571153
MACD Line 0.0923
MACD Signal Line 0.0393
MACD Histogram 0.0531
Fundamentals Value
Market Cap 112.7 Million
Num Shares 26.5 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -8.17
Price-to-Sales 0.00
Price-to-Book 3.88
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.49
Resistance 3 (R3) 4.50 4.42 4.45
Resistance 2 (R2) 4.42 4.36 4.42 4.44
Resistance 1 (R1) 4.34 4.32 4.30 4.33 4.42
Pivot Point 4.26 4.26 4.25 4.26 4.26
Support 1 (S1) 4.18 4.20 4.14 4.17 4.08
Support 2 (S2) 4.10 4.16 4.10 4.06
Support 3 (S3) 4.02 4.10 4.05
Support 4 (S4) 4.01